Irinotecan
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients (NCT06169202) | China Medical University, China | 2023-06-01 |
Track Irinotecan automatically
Every clearance here is in the API, with alerts when new ones post.